Global Human Coagulation Factor VIII Sales Market Report 2024
The global Human Coagulation Factor VIII market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Coagulation Factor VIII market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Recombinant Factor VIII
Plasma-derived Factor VIII
Segment by Application
Hemophilia A
Spontanous / Trauma
Surgical
Other
The Human Coagulation Factor VIII market is analysed and market size information is provided by regions (countries).
Segment by Application
, the Human Coagulation Factor VIII market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Shire (Baxter)
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS

Table of Content
1 Human Coagulation Factor VIII Market Overview
1.1 Human Coagulation Factor VIII Product Scope
1.2 Human Coagulation Factor VIII Segment by Type
1.2.1 Global Human Coagulation Factor VIII Sales by Type (2016 & 2021 & 2027)
1.2.2 Recombinant Factor VIII
1.2.3 Plasma-derived Factor VIII
1.3 Human Coagulation Factor VIII Segment by Application
1.3.1 Global Human Coagulation Factor VIII Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Hemophilia A
1.3.3 Spontanous / Trauma
1.3.4 Surgical
1.3.5 Other
1.4 Human Coagulation Factor VIII Market Estimates and Forecasts (2016-2027)
1.4.1 Global Human Coagulation Factor VIII Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Human Coagulation Factor VIII Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Human Coagulation Factor VIII Price Trends (2016-2027)
2 Human Coagulation Factor VIII Estimates and Forecasts by Region
2.1 Global Human Coagulation Factor VIII Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Human Coagulation Factor VIII Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Human Coagulation Factor VIII Sales Market Share by Region (2016-2021)
2.2.2 Global Human Coagulation Factor VIII Revenue Market Share by Region (2016-2021)
2.3 Global Human Coagulation Factor VIII Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Human Coagulation Factor VIII Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Human Coagulation Factor VIII Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Human Coagulation Factor VIII Estimates and Projections (2016-2027)
2.4.2 Europe Human Coagulation Factor VIII Estimates and Projections (2016-2027)
2.4.3 China Human Coagulation Factor VIII Estimates and Projections (2016-2027)
2.4.4 Japan Human Coagulation Factor VIII Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Human Coagulation Factor VIII Estimates and Projections (2016-2027)
2.4.6 India Human Coagulation Factor VIII Estimates and Projections (2016-2027)
3 Global Human Coagulation Factor VIII Competition Landscape by Players
3.1 Global Top Human Coagulation Factor VIII Players by Sales (2016-2021)
3.2 Global Top Human Coagulation Factor VIII Players by Revenue (2016-2021)
3.3 Global Human Coagulation Factor VIII Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Coagulation Factor VIII as of 2020)
3.4 Global Human Coagulation Factor VIII Average Price by Company (2016-2021)
3.5 Manufacturers Human Coagulation Factor VIII Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Human Coagulation Factor VIII Market Size by Type
4.1 Global Human Coagulation Factor VIII Historic Market Review by Type (2016-2021)
4.1.1 Global Human Coagulation Factor VIII Sales Market Share by Type (2016-2021)
4.1.2 Global Human Coagulation Factor VIII Revenue Market Share by Type (2016-2021)
4.1.3 Global Human Coagulation Factor VIII Price by Type (2016-2021)
4.2 Global Human Coagulation Factor VIII Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Human Coagulation Factor VIII Sales Forecast by Type (2022-2027)
4.2.2 Global Human Coagulation Factor VIII Revenue Forecast by Type (2022-2027)
4.2.3 Global Human Coagulation Factor VIII Price Forecast by Type (2022-2027)
5 Global Human Coagulation Factor VIII Market Size by Application
5.1 Global Human Coagulation Factor VIII Historic Market Review by Application (2016-2021)
5.1.1 Global Human Coagulation Factor VIII Sales Market Share by Application (2016-2021)
5.1.2 Global Human Coagulation Factor VIII Revenue Market Share by Application (2016-2021)
5.1.3 Global Human Coagulation Factor VIII Price by Application (2016-2021)
5.2 Global Human Coagulation Factor VIII Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Human Coagulation Factor VIII Sales Forecast by Application (2022-2027)
5.2.2 Global Human Coagulation Factor VIII Revenue Forecast by Application (2022-2027)
5.2.3 Global Human Coagulation Factor VIII Price Forecast by Application (2022-2027)
6 North America Human Coagulation Factor VIII Market Facts & Figures
6.1 North America Human Coagulation Factor VIII Sales by Company
6.1.1 North America Human Coagulation Factor VIII Sales by Company (2016-2021)
6.1.2 North America Human Coagulation Factor VIII Revenue by Company (2016-2021)
6.2 North America Human Coagulation Factor VIII Sales Breakdown by Type
6.2.1 North America Human Coagulation Factor VIII Sales Breakdown by Type (2016-2021)
6.2.2 North America Human Coagulation Factor VIII Sales Breakdown by Type (2022-2027)
6.3 North America Human Coagulation Factor VIII Sales Breakdown by Application
6.3.1 North America Human Coagulation Factor VIII Sales Breakdown by Application (2016-2021)
6.3.2 North America Human Coagulation Factor VIII Sales Breakdown by Application (2022-2027)
7 Europe Human Coagulation Factor VIII Market Facts & Figures
7.1 Europe Human Coagulation Factor VIII Sales by Company
7.1.1 Europe Human Coagulation Factor VIII Sales by Company (2016-2021)
7.1.2 Europe Human Coagulation Factor VIII Revenue by Company (2016-2021)
7.2 Europe Human Coagulation Factor VIII Sales Breakdown by Type
7.2.1 Europe Human Coagulation Factor VIII Sales Breakdown by Type (2016-2021)
7.2.2 Europe Human Coagulation Factor VIII Sales Breakdown by Type (2022-2027)
7.3 Europe Human Coagulation Factor VIII Sales Breakdown by Application
7.3.1 Europe 147 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 147 Sales Breakdown by Application (2022-2027)
8 China Human Coagulation Factor VIII Market Facts & Figures
8.1 China Human Coagulation Factor VIII Sales by Company
8.1.1 China Human Coagulation Factor VIII Sales by Company (2016-2021)
8.1.2 China Human Coagulation Factor VIII Revenue by Company (2016-2021)
8.2 China Human Coagulation Factor VIII Sales Breakdown by Type
8.2.1 China Human Coagulation Factor VIII Sales Breakdown by Type (2016-2021)
8.2.2 China Human Coagulation Factor VIII Sales Breakdown by Type (2022-2027)
8.3 China Human Coagulation Factor VIII Sales Breakdown by Application
8.3.1 China 313 Sales Breakdown by Application (2016-2021)
8.3.2 China 313 Sales Breakdown by Application (2022-2027)
9 Japan Human Coagulation Factor VIII Market Facts & Figures
9.1 Japan Human Coagulation Factor VIII Sales by Company
9.1.1 Japan Human Coagulation Factor VIII Sales by Company (2016-2021)
9.1.2 Japan Human Coagulation Factor VIII Revenue by Company (2016-2021)
9.2 Japan Human Coagulation Factor VIII Sales Breakdown by Type
9.2.1 Japan Human Coagulation Factor VIII Sales Breakdown by Type (2016-2021)
9.2.2 Japan Human Coagulation Factor VIII Sales Breakdown by Type (2022-2027)
9.3 Japan Human Coagulation Factor VIII Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Human Coagulation Factor VIII Market Facts & Figures
10.1 Southeast Asia Human Coagulation Factor VIII Sales by Company
10.1.1 Southeast Asia Human Coagulation Factor VIII Sales by Company (2016-2021)
10.1.2 Southeast Asia Human Coagulation Factor VIII Revenue by Company (2016-2021)
10.2 Southeast Asia Human Coagulation Factor VIII Sales Breakdown by Type
10.2.1 Southeast Asia Human Coagulation Factor VIII Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Human Coagulation Factor VIII Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Human Coagulation Factor VIII Sales Breakdown by Application
10.3.1 Southeast Asia Kg Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia Kg Sales Breakdown by Application (2022-2027)
11 India Human Coagulation Factor VIII Market Facts & Figures
11.1 India Human Coagulation Factor VIII Sales by Company
11.1.1 India Human Coagulation Factor VIII Sales by Company (2016-2021)
11.1.2 India Human Coagulation Factor VIII Revenue by Company (2016-2021)
11.2 India Human Coagulation Factor VIII Sales Breakdown by Type
11.2.1 India Human Coagulation Factor VIII Sales Breakdown by Type (2016-2021)
11.2.2 India Human Coagulation Factor VIII Sales Breakdown by Type (2022-2027)
11.3 India Human Coagulation Factor VIII Sales Breakdown by Application
11.3.1 India Human Coagulation Factor VIII Sales Breakdown by Application (2016-2021)
11.3.2 India Human Coagulation Factor VIII Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Human Coagulation Factor VIII Business
12.1 Shire (Baxter)
12.1.1 Shire (Baxter) Corporation Information
12.1.2 Shire (Baxter) Business Overview
12.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Shire (Baxter) Human Coagulation Factor VIII Products Offered
12.1.5 Shire (Baxter) Recent Development
12.2 Bayer
12.2.1 Bayer Corporation Information
12.2.2 Bayer Business Overview
12.2.3 Bayer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Bayer Human Coagulation Factor VIII Products Offered
12.2.5 Bayer Recent Development
12.3 CSL
12.3.1 CSL Corporation Information
12.3.2 CSL Business Overview
12.3.3 CSL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.3.4 CSL Human Coagulation Factor VIII Products Offered
12.3.5 CSL Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Business Overview
12.4.3 Pfizer Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Pfizer Human Coagulation Factor VIII Products Offered
12.4.5 Pfizer Recent Development
12.5 Grifols
12.5.1 Grifols Corporation Information
12.5.2 Grifols Business Overview
12.5.3 Grifols Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Grifols Human Coagulation Factor VIII Products Offered
12.5.5 Grifols Recent Development
12.6 Biogen
12.6.1 Biogen Corporation Information
12.6.2 Biogen Business Overview
12.6.3 Biogen Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Biogen Human Coagulation Factor VIII Products Offered
12.6.5 Biogen Recent Development
12.7 Octapharma
12.7.1 Octapharma Corporation Information
12.7.2 Octapharma Business Overview
12.7.3 Octapharma Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Octapharma Human Coagulation Factor VIII Products Offered
12.7.5 Octapharma Recent Development
12.8 NovoNordisk
12.8.1 NovoNordisk Corporation Information
12.8.2 NovoNordisk Business Overview
12.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.8.4 NovoNordisk Human Coagulation Factor VIII Products Offered
12.8.5 NovoNordisk Recent Development
12.9 Greencross
12.9.1 Greencross Corporation Information
12.9.2 Greencross Business Overview
12.9.3 Greencross Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Greencross Human Coagulation Factor VIII Products Offered
12.9.5 Greencross Recent Development
12.10 Kedrion
12.10.1 Kedrion Corporation Information
12.10.2 Kedrion Business Overview
12.10.3 Kedrion Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Kedrion Human Coagulation Factor VIII Products Offered
12.10.5 Kedrion Recent Development
12.11 BPL
12.11.1 BPL Corporation Information
12.11.2 BPL Business Overview
12.11.3 BPL Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.11.4 BPL Human Coagulation Factor VIII Products Offered
12.11.5 BPL Recent Development
12.12 Hualan Bio
12.12.1 Hualan Bio Corporation Information
12.12.2 Hualan Bio Business Overview
12.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Hualan Bio Human Coagulation Factor VIII Products Offered
12.12.5 Hualan Bio Recent Development
12.13 RAAS
12.13.1 RAAS Corporation Information
12.13.2 RAAS Business Overview
12.13.3 RAAS Human Coagulation Factor VIII Sales, Revenue and Gross Margin (2016-2021)
12.13.4 RAAS Human Coagulation Factor VIII Products Offered
12.13.5 RAAS Recent Development
13 Human Coagulation Factor VIII Manufacturing Cost Analysis
13.1 Human Coagulation Factor VIII Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Human Coagulation Factor VIII
13.4 Human Coagulation Factor VIII Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Human Coagulation Factor VIII Distributors List
14.3 Human Coagulation Factor VIII Customers
15 Market Dynamics
15.1 Human Coagulation Factor VIII Market Trends
15.2 Human Coagulation Factor VIII Drivers
15.3 Human Coagulation Factor VIII Market Challenges
15.4 Human Coagulation Factor VIII Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer